135 related articles for article (PubMed ID: 21861705)
1. Photodynamic therapy using an anti-EGF receptor antibody complexed with verteporfin nanoparticles: a proof of concept study.
Kameyama N; Matsuda S; Itano O; Ito A; Konno T; Arai T; Ishihara K; Ueda M; Kitagawa Y
Cancer Biother Radiopharm; 2011 Dec; 26(6):697-704. PubMed ID: 21861705
[TBL] [Abstract][Full Text] [Related]
2. Development of targeted therapy with paclitaxel incorporated into EGF-conjugated nanoparticles.
Shimada T; Ueda M; Jinno H; Chiba N; Wada M; Watanabe J; Ishihara K; Kitagawa Y
Anticancer Res; 2009 Apr; 29(4):1009-14. PubMed ID: 19414339
[TBL] [Abstract][Full Text] [Related]
3. Selective targeting by preS1 domain of hepatitis B surface antigen conjugated with phosphorylcholine-based amphiphilic block copolymer micelles as a biocompatible, drug delivery carrier for treatment of human hepatocellular carcinoma with paclitaxel.
Miyata R; Ueda M; Jinno H; Konno T; Ishihara K; Ando N; Kitagawa Y
Int J Cancer; 2009 May; 124(10):2460-7. PubMed ID: 19173297
[TBL] [Abstract][Full Text] [Related]
4. Preclinical comparison of mTHPC and verteporfin for intracavitary photodynamic therapy of malignant pleural mesothelioma.
Opitz I; Krueger T; Pan Y; Altermatt HJ; Wagnières G; Ris HB
Eur Surg Res; 2006; 38(3):333-9. PubMed ID: 16785733
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy with verteporfin in the radiation-induced fibrosarcoma-1 tumor causes enhanced radiation sensitivity.
Pogue BW; O'Hara JA; Demidenko E; Wilmot CM; Goodwin IA; Chen B; Swartz HM; Hasan T
Cancer Res; 2003 Mar; 63(5):1025-33. PubMed ID: 12615718
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy of multiple nonmelanoma skin cancers with verteporfin and red light-emitting diodes: two-year results evaluating tumor response and cosmetic outcomes.
Lui H; Hobbs L; Tope WD; Lee PK; Elmets C; Provost N; Chan A; Neyndorff H; Su XY; Jain H; Hamzavi I; McLean D; Bissonnette R
Arch Dermatol; 2004 Jan; 140(1):26-32. PubMed ID: 14732656
[TBL] [Abstract][Full Text] [Related]
7. The Noninvasive Treatment for Sentinel Lymph Node Metastasis by Photodynamic Therapy Using Phospholipid Polymer as a Nanotransporter of Verteporfin.
Shimada K; Matsuda S; Jinno H; Kameyama N; Konno T; Arai T; Ishihara K; Kitagawa Y
Biomed Res Int; 2017; 2017():7412865. PubMed ID: 28473989
[No Abstract] [Full Text] [Related]
8. Verteporfin, photofrin II, and merocyanine 540 as PDT photosensitizers against melanoma cells.
Nowak-Sliwinska P; Karocki A; Elas M; Pawlak A; Stochel G; Urbanska K
Biochem Biophys Res Commun; 2006 Oct; 349(2):549-55. PubMed ID: 16945338
[TBL] [Abstract][Full Text] [Related]
9. Antibody-targeted photodynamic therapy.
Mayo GL; Melendez RF; Kumar N; McKinnon SJ; Glickman RD
Am J Ophthalmol; 2003 Dec; 136(6):1151-2. PubMed ID: 14644227
[TBL] [Abstract][Full Text] [Related]
10. Disparity between prostate tumor interior versus peripheral vasculature in response to verteporfin-mediated vascular-targeting therapy.
Chen B; Crane C; He C; Gondek D; Agharkar P; Savellano MD; Hoopes PJ; Pogue BW
Int J Cancer; 2008 Aug; 123(3):695-701. PubMed ID: 18498134
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
[TBL] [Abstract][Full Text] [Related]
12. Targeting tissue factor on tumour cells and angiogenic vascular endothelial cells by factor VII-targeted verteporfin photodynamic therapy for breast cancer in vitro and in vivo in mice.
Hu Z; Rao B; Chen S; Duanmu J
BMC Cancer; 2010 May; 10():235. PubMed ID: 20504328
[TBL] [Abstract][Full Text] [Related]
13. Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2.
Renno RZ; Terada Y; Haddadin MJ; Michaud NA; Gragoudas ES; Miller JW
Arch Ophthalmol; 2004 Jul; 122(7):1002-11. PubMed ID: 15249365
[TBL] [Abstract][Full Text] [Related]
14. Effect of tumor host microenvironment on photodynamic therapy in a rat prostate tumor model.
Chen B; Pogue BW; Zhou X; O'Hara JA; Solban N; Demidenko E; Hoopes PJ; Hasan T
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):720-7. PubMed ID: 15701861
[TBL] [Abstract][Full Text] [Related]
15. Defining the therapeutic window of vertebral photodynamic therapy in a murine pre-clinical model of breast cancer metastasis using the photosensitizer BPD-MA (Verteporfin).
Akens MK; Hardisty MR; Wilson BC; Schwock J; Whyne CM; Burch S; Yee AJ
Breast Cancer Res Treat; 2010 Jan; 119(2):325-33. PubMed ID: 19263216
[TBL] [Abstract][Full Text] [Related]
16. Long-term regression of the murine mammary adenocarcinoma, LM3, by repeated photodynamic treatments using meso-tetra (4-N-methylpyridinium) porphine.
Colombo LL; Vanzulli SI; Villanueva A; Cañete M; Juarranz A; Stockert JC
Int J Oncol; 2005 Oct; 27(4):1053-9. PubMed ID: 16142323
[TBL] [Abstract][Full Text] [Related]
17. Comparison between endothelial and tumor cells in the response to verteporfin-photodynamic therapy and a PI3K pathway inhibitor.
Fateye B; Wan A; Yang X; Myers K; Chen B
Photodiagnosis Photodyn Ther; 2015 Mar; 12(1):19-26. PubMed ID: 25636781
[TBL] [Abstract][Full Text] [Related]
18. Contact transscleral ciliary body photodynamic therapy in pigmented rabbits using verteporfin and diode laser: evaluation of treatment parameters.
Tsilimbaris MK; Charisis SK; Naoumidi T; Panteleontidis V; Skondra D; Christodoulakis E; Naoumidi I
Curr Eye Res; 2006; 31(7-8):577-85. PubMed ID: 16877266
[TBL] [Abstract][Full Text] [Related]
19. Selenium enhances the efficacy of Radachlorin mediated-photodynamic therapy in TC-1 tumor development.
Kim YW; Bae SM; Liu HB; Kim IW; Chun HJ; Ahn WS
Oncol Rep; 2012 Aug; 28(2):576-84. PubMed ID: 22614712
[TBL] [Abstract][Full Text] [Related]
20. Targeting of a hydrophilic photosensitizer by use of internalizing monoclonal antibodies: A new possibility for use in photodynamic therapy.
Vrouenraets MB; Visser GW; Loup C; Meunier B; Stigter M; Oppelaar H; Stewart FA; Snow GB; van Dongen GA
Int J Cancer; 2000 Oct; 88(1):108-14. PubMed ID: 10962447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
